Trade Pfizer ^PFE

Health Care Up After Earnings - Health Care Roundup | Morningstar

Pfizer Earnings: Strong First-Quarter Performance Makes 2026 Guidance More Achievable | Morningstar

Down as Much as 55% and Still Magnificent: 3 Dividend Stocks Worth Holding for a Lifetime

Pfizer CEO Sees CDC Director Pick Restoring Agency's Credibility

Pfizer Beats Sales Estimates As $17 Billion Patent Cliff Looms

Pfizer beats Q1 revenue and profit estimates, reaffirms 2026 guidance

US market today: Pfizer posts strong first-quarter, sees boost from recent legal wins - The Economic Times

Dow Jones Top Company Headlines at 11 AM ET: Pfizer Posts Better-Than-Expected Revenue, Profit | Coinbase ... | Morningstar

Pfizer (NYSE:PFE) Issues Earnings Results

Dow Jones Top Company Headlines at 9 AM ET: Pfizer Posts Better-Than-Expected Revenue, Profit | Coinbase ... | Morningstar

Pfizer (NYSE:PFE) Issues FY 2026 Earnings Guidance - Zolmax

Accenture CEO on the lesson that changed her life

How Pfizer's CEO says he uses AI to make decisions

Pfizer Q1 Profit Drops, Revenues Rise; Backs FY26 Outlook - Update

Pfizer (PFE) Stock Climbs as Eliquis Drives Strong Q1 Earnings Performance

CELYSTRA Pharma: Trio of Industry Veterans Launches Quebec Biopharmaceutical Company to Bring Innovative Treatments to Canada

Pfizer (PFE) earnings Q1 2026

QRG Capital Management Inc. Raises Holdings in Pfizer Inc. $PFE

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

Truist Financial Corp Decreases Stake in Pfizer Inc. $PFE

Stock Index Futures Climb as U.S.-Iran Ceasefire Holds, JOLTs Report and Earnings in Focus

Pfizer Q1 26 Earnings Conference Call At 10:00 AM ET

Pfizer (NYSE:PFE) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPS - Daily Political

Pfizer Inc. $PFE Shares Sold by Seizert Capital Partners LLC - Daily Political

Pfizer Earnings: What To Look For From PFE

AMD and Pfizer earnings, job openings, Fedspeak: What to Watch

DuPont (DD) Earnings Report Expected Tomorrow

Pfizer (PFE) Prepares for Q1 Earnings Amid Optimism on Growth Prospects

Jim Cramer on Pfizer: "If I Want Good Yield, I'll Buy a Bond" - Insider Monkey

Relay Therapeutics (RLAY) Is Down 14.9% After Zovegalisib Triplet Data And Phase 3 Plans With Pfizer - Has The Bull Case Changed?

Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era

Celcuity's gedatolisib beats Novartis' Piqray in phase 3 breast cancer study

Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend

Horizon Investments LLC Lowers Stake in Pfizer Inc. $PFE

Pfizer Stock: Still Priced Like It's Dead Money - AOL

Assessing Novavax (NVAX) Valuation As Licensing Pivot And Key Vaccine Readout Approach

CENTRAL TRUST Co Sells 85,365 Shares of Pfizer Inc. $PFE

Wilkins Investment Counsel Inc. Decreases Stock Position in Pfizer Inc. $PFE - Stock Observer

Guggenheim Reaffirms Buy on Pfizer (PFE) Ahead of Pipeline Catalysts

Does VYNDAMAX Exclusivity To 2031 And ELREXFIO Data Change The Bull Case For Pfizer (PFE)?

Relay Therapeutics (RLAY) Valuation Check After Advancing Zovegalisib Combination Into Phase 3 Development

GC Wealth Management RIA LLC Sells 48,783 Shares of Pfizer Inc. $PFE - Daily Political

Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries

Pfizer (NYSE:PFE) Stock Price Down 1.3% - Here's Why

Pfizer (PFE) and Arvinas (ARVN) Gain FDA Approval for Breast Cancer Therapy Veppanu

Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer | Taiwan News | May. 2, 2026 00:43

US FDA approves Pfizer, Arvinas' breast cancer drug - AOL

Pfizer Inc. $PFE Shares Sold by New York State Teachers Retirement System

Danske Bank A S Buys 229,304 Shares of Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Sold by US Bancorp DE - Stock Observer

Pfizer (NYSE:PFE) Trading 1.8% Higher - Should You Buy?

Pfizer (PFE) Among Best Medical Stocks Under $30 to Invest In?

Vest Financial LLC Boosts Stock Holdings in Pfizer Inc. $PFE

$4+ Billion OTC Dry Eye Drops Market Analysis Report 2026: Pfizer, Johnson & Johnson Services, and Novartis International Dominate

Pfizer (PFE) Reaches Settlement to Extend VYNDAMAX Patent Protection Until 2031

5 Innovative Dividend Stocks to Buy Right Now

5 Innovative Dividend Stocks to Buy Now

For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health | Taiwan News | Apr. 30, 2026 16:14

Valneva annonce le succès d'une Offre Réservée d'un montant de 84 millions d'euros

Valneva Announces the Successful Completion of an €84 million Reserved Offering

Pfizer's Elrexfio Shows Promise in Late-Stage Trial for Blood Cancer Treatment, ETPharma

9 Most Active US Stocks to Buy Right Now

Pfizer Inc. $PFE Shares Sold by Pictet Asset Management Holding SA - Daily Political

PFE Maintained by Citigroup -- Price Target Raised to $27.00

Pfizer (PFE) Reports Positive Trial Results for Elrexfio in Multiple Myeloma

Clinical Trials Market Analysis/Forecasts 2026-2034 by Phases, Indications, Study Designs, Countries and Competitive Landscape

Pfizer Inc. $PFE Shares Bought by Wealthfront Advisers LLC

Pfizer (PFE) Reports Encouraging Results for ELREXFIO in Multiple Myeloma Study

Pfizer's blood cancer drug meets main goal in late-stage trial - AOL

Pfizer's blood cancer drug meets main goal in late-stage trial - Yahoo News Canada

Pfizer Inc. $PFE Shares Bought by Mitsubishi UFJ Trust & Banking Corp

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Cardinal Capital Management Takes Position in Pfizer Inc. $PFE

Is Pfizer (PFE) Offering Value After Recent Share Price Weakness?

Evolutionary characterization of lung cancer metastasis

Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort

Pfizer (NYSE:PFE) Shares Down 1.3% - Here's What Happened

Pfizer (PFE) Secures Patent Settlement, Extending Vyndamax Protection

Pfizer (PFE) Confirms Tafamidis Settlement, Shares Receive Boost

Company Website: https://www.pfizer.com NEW YORK -- (Busin

Pfizer Settles Patent Disputes, Extends VYNDAMAX Exclusivity To 2031

Pfizer Drops Hikma From Vyndamax Patent Lawsuit, Ending Trial

Pfizer (PFE) Secures Tafamidis Patent Extension Through 2031

Direct Relief and the Pfizer Foundation Announce New Grantees in Fifth Year of Infectious Disease Program

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Pfizer Reaches Three Settlement Agreements for VYNDAMAX | Morningstar

Are Wall Street Analysts Bullish on Pfizer Stock?

Merck Broadens Growth Story With Heart Campaign And New Drug Approvals

Pfizer (PFE) Projected to Post Earnings on Tuesday

ESR1 Mutated Metastatic Breast Cancer Market Research Report 2026: Epidemiological Analysis, Competitive Landscape, Regulatory Landscape, Pipeline Analysis, M&A, Regulatory Activities, Funding,

Pancreatic Neuroendocrine Tumors Market Research Report 2025-2035, Competitive Analysis of Key Players - Novartis, Pfizer, Exelixis, Merck, Ipsen Pharma, and Takeda Pharma

Relay Therapeutics Unveils Zovegalisib Triplet Data, Signs Pfizer Supply Deal for Phase III Plan

Pimco's Triumph in 2025: A Bold Bond Strategy Pays Off

Fed Independence on the Line? Political Influence in 2026

US Holiday Shopping Season: Record Online Sales Amid Economic Vulnerabilities

US Economic Outlook 2026: A Roubini Analysis

Fed's Divergent Votes: A Sign of Policy Uncertainty?

Trading wisdom: how can I improve myself as a trader?

Can you trade CFDs on crypto: platform to trade cryptocurrency CFDs

EQV stock price today: Is EQV Ventures a good investment?

How to start investing in dividend ETFs: 7 Dividend ETFs to Watch

TSLQ ETF price forecast: How to track TSLQ ETF prices?

Russia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict

US Economic Signals: Inflation Concerns and Growth Challenges

Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions

Apple Slashes App Store Commissions in China for Developers

Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis

Aussie Dollar Sees Surge in Bullish Bets Ahead of Reserve Bank of Australia Rate Decision

India's Silver Demand Surge: New Loan Framework Boosts Market

ADP Employment Data and the Fed's Policy Path: A Closer Look